133 related articles for article (PubMed ID: 38219875)
1. LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.
Wasson MD; Venkatesh J; Cahill HF; McLean ME; Dean CA; Marcato P
Gene; 2024 Apr; 901():148165. PubMed ID: 38219875
[TBL] [Abstract][Full Text] [Related]
2. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.
Cedro-Tanda A; Ríos-Romero M; Romero-Córdoba S; Cisneros-Villanueva M; Rebollar-Vega RG; Alfaro-Ruiz LA; Jiménez-Morales S; Domínguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Bautista-Piña V; Beltrán-Anaya FO; Hidalgo-Miranda A
Sci Rep; 2020 Aug; 10(1):13146. PubMed ID: 32753692
[TBL] [Abstract][Full Text] [Related]
3. Portraying breast cancers with long noncoding RNAs.
Van Grembergen O; Bizet M; de Bony EJ; Calonne E; Putmans P; Brohée S; Olsen C; Guo M; Bontempi G; Sotiriou C; Defrance M; Fuks F
Sci Adv; 2016 Sep; 2(9):e1600220. PubMed ID: 27617288
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic long noncoding RNA landscape in breast cancer.
Xu S; Kong D; Chen Q; Ping Y; Pang D
Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
[TBL] [Abstract][Full Text] [Related]
5. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
6. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-mediated regulation of
Tariq A; Hao Q; Sun Q; Singh DK; Jadaliha M; Zhang Y; Chetlangia N; Ma J; Holton SE; Bhargava R; Lal A; Prasanth SG; Prasanth KV
RNA; 2020 Feb; 26(2):175-185. PubMed ID: 31690584
[TBL] [Abstract][Full Text] [Related]
8. Subtype and cell type specific expression of lncRNAs provide insight into breast cancer.
Bjørklund SS; Aure MR; Häkkinen J; Vallon-Christersson J; Kumar S; Evensen KB; Fleischer T; Tost J; ; Sahlberg KK; Mathelier A; Bhanot G; Ganesan S; Tekpli X; Kristensen VN
Commun Biol; 2022 Aug; 5(1):834. PubMed ID: 35982125
[TBL] [Abstract][Full Text] [Related]
9. BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis.
Barton M; Santucci-Pereira J; Vaccaro OG; Nguyen T; Su Y; Russo J
BMC Cancer; 2019 Oct; 19(1):994. PubMed ID: 31646972
[TBL] [Abstract][Full Text] [Related]
10. Primate-specific oestrogen-responsive long non-coding RNAs regulate proliferation and viability of human breast cancer cells.
Lin CY; Kleinbrink EL; Dachet F; Cai J; Ju D; Goldstone A; Wood EJ; Liu K; Jia H; Goustin AS; Kosir MA; Thepsuwan P; Lipovich L
Open Biol; 2016 Dec; 6(12):. PubMed ID: 28003470
[TBL] [Abstract][Full Text] [Related]
11. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer.
Cisneros-Villanueva M; Fonseca-Montaño MA; Ríos-Romero M; López-Camarillo C; Jiménez-Morales S; Langley E; Rosette-Rueda AS; Cedro-Tanda A; Hernández-Sotelo D; Hidalgo-Miranda A
Sci Rep; 2024 Jan; 14(1):1483. PubMed ID: 38233470
[TBL] [Abstract][Full Text] [Related]
13. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
14. Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
Ma X; Yu L; Wang P; Yang X
Comput Biol Chem; 2017 Aug; 69():164-170. PubMed ID: 28501295
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs as prognostic markers in human breast cancer.
Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY
Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882
[TBL] [Abstract][Full Text] [Related]
17. Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Tracy KM; Tye CE; Page NA; Fritz AJ; Stein JL; Lian JB; Stein GS
J Cell Physiol; 2018 Feb; 233(2):1291-1299. PubMed ID: 28488769
[TBL] [Abstract][Full Text] [Related]
18. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Jiang Z; Slater CM; Zhou Y; Devarajan K; Ruth KJ; Li Y; Cai KQ; Daly M; Chen X
Breast Cancer Res; 2017 May; 19(1):62. PubMed ID: 28558830
[TBL] [Abstract][Full Text] [Related]
19. Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Bradford JR; Cox A; Bernard P; Camp NJ
PLoS One; 2016; 11(9):e0163238. PubMed ID: 27685983
[TBL] [Abstract][Full Text] [Related]
20. Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer.
Zhao Z; Guo Y; Liu Y; Sun L; Chen B; Wang C; Chen T; Wang Y; Li Y; Dong Q; Ai L; Wang R; Gu Y; Li X
Oncogene; 2021 Jul; 40(27):4604-4614. PubMed ID: 34131286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
